Literature DB >> 22186784

c-MYB and TGFβ: EMT's dynamic duo in breast cancer.

Arturo Sala.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22186784     DOI： 10.4161/cc.11.1.18733

Source DB:  PubMed          Journal:  Cell Cycle        ISSN： 1551-4005            Impact factor:   4.534


× No keyword cloud information.
  3 in total

Review 1.  Deregulation of the EGFR/PI3K/PTEN/Akt/mTORC1 pathway in breast cancer: possibilities for therapeutic intervention.

Authors:  Nicole M Davis; Melissa Sokolosky; Kristin Stadelman; Steve L Abrams; Massimo Libra; Saverio Candido; Ferdinando Nicoletti; Jerry Polesel; Roberta Maestro; Antonino D'Assoro; Lyudmyla Drobot; Dariusz Rakus; Agnieszka Gizak; Piotr Laidler; Joanna Dulińska-Litewka; Joerg Basecke; Sanja Mijatovic; Danijela Maksimovic-Ivanic; Giuseppe Montalto; Melchiorre Cervello; Timothy L Fitzgerald; Zoya Demidenko; Alberto M Martelli; Lucio Cocco; Linda S Steelman; James A McCubrey
Journal:  Oncotarget       Date:  2014-07-15

2.  Overexpression of MYBL2 promotes proliferation and migration of non-small-cell lung cancer via upregulating NCAPH.

Authors:  Yu-Chao Xiong; Jiao Wang; Yong Cheng; Xin-Yi Zhang; Xiao-Qun Ye
Journal:  Mol Cell Biochem       Date:  2020-03-21       Impact factor: 3.396

3.  Activation of miR200 by c-Myb depends on ZEB1 expression and miR200 promoter methylation.

Authors:  Marco Pieraccioli; Francesca Imbastari; Alexey Antonov; Gerry Melino; Giuseppe Raschellà
Journal:  Cell Cycle       Date:  2013-07-15       Impact factor: 4.534
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.